Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ofatumumab Regimens in Less Fit CLL
NCT01678430Phase 3Unknown
- Sponsor
- University of Liverpool
- Start
- Dec 2011
- Primary completion
- Dec 2017
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of ofatumumab in chronic lymphocytic leukemia (CLL), sponsored by University of Liverpool. Status: unknown.
02
Drugs
ofatumumab
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT01678430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01678430.